文献速递瓣膜病与结构性心脏病

脂蛋白(a)对轻中度主动脉瓣狭窄患者钙化活动无主要影响

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis.
PubMed 文献 · Heart · 2021-09-30

本研究在轻中度主动脉瓣狭窄患者中,按年龄、性别、峰值主动脉射流速度和瓣膜形态匹配高脂蛋白(a)(>50 mg/dL)与低脂蛋白(a)(<50 mg/dL)者,用18F-NaF PET/CT比较瓣膜钙化活动。共纳入52人(26对),结果显示两组瓣膜18F-NaF摄取无差异(3.02±1.26 vs 3.05±0.96,p=0.902);瓣膜钙评分是摄取的唯一显著决定因素。结论不支持脂蛋白(a)与瓣膜钙化活动相关的假设。

要点

  • 轻中度主动脉瓣狭窄患者中,高脂蛋白(a)与低脂蛋白(a)组瓣膜18F-NaF摄取无差异。
  • 瓣膜钙评分是瓣膜18F-NaF摄取的唯一显著决定因素。
  • 脂蛋白(a)未显示与瓣膜钙化活动独立相关。

核心结论

  • 在轻中度主动脉瓣狭窄患者中,钙化活动主要由已存在的钙负荷决定,脂蛋白(a)与瓣膜18F-NaF摄取无关。

研究设计与样本

  • 在峰值主动脉射流速度2–4 m/s的轻中度主动脉瓣狭窄患者中,行18F-NaF PET/CT。
  • 比较高脂蛋白(a)(>50 mg/dL)与低脂蛋白(a)(<50 mg/dL)患者,按年龄、性别、峰值主动脉射流速度和瓣膜形态匹配。
  • 共纳入52人(26对匹配),平均年龄66.4±5.5岁,44人(84.6%)为男性,平均主动脉瓣速度2.80±0.49 m/s。

主要发现

  • 高脂蛋白(a)组中位脂蛋白(a)为79(64–117)mg/dL,低脂蛋白(a)组为7(5–11)mg/dL。
  • 低脂蛋白(a)组收缩压和校正脂蛋白(a)后的低密度脂蛋白胆固醇显著更高(141±12 vs 128±12 mm Hg;2.5±1.1 vs 1.9±0.8 mmol/L)。
  • 两组瓣膜18F-NaF摄取无差异(3.02±1.26 vs 3.05±0.96,p=0.902)。
  • 线性回归显示瓣膜钙评分是瓣膜18F-NaF摄取的唯一显著决定因素(每增加1000 Agatston单位β=0.63;95% CI 0.38–0.88,p<0.001)。
  • 高脂蛋白(a)组与18F-NaF摄取无关(β=0.17;95% CI -0.44–0.88,p=0.305)。

关键数值与推荐

  • 脂蛋白(a)分组阈值:高脂蛋白(a)为>50 mg/dL,低脂蛋白(a)为<50 mg/dL。
  • 主动脉瓣狭窄严重程度:峰值主动脉射流速度2–4 m/s。
  • 瓣膜18F-NaF摄取采用靶本底比值和最病变节段法比较。

临床怎么用

  • 对于轻中度主动脉瓣狭窄患者,脂蛋白(a)水平不宜作为瓣膜钙化活动的主要评估指标。
  • 瓣膜钙评分与18F-NaF摄取相关,提示已存在钙负荷是钙化活动的主要决定因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether patients with aortic valve stenosis (AS) with elevated lipoprotein(a) (Lp(a)) are characterised by increased valvular calcification activity compared with those with low Lp(a). METHODS: We performed 18F-sodium fluoride (18F-NaF) positron emission tomography/CT in patients with mild to moderate AS (peak aortic jet velocity between 2 and 4 m/s) and high versus low Lp(a) (>50 mg/dL vs <50 mg/dL, respectively). Subjects were matched according to age, gender, peak aortic jet velocity and valve morphology. We used a target to background ratio with the most diseased segment approach to compare 18F-NaF uptake. RESULTS: 52 individuals (26 matched pairs) were included in the analysis. The mean age was 66.4±5.5 years, 44 (84.6%) were men, and the mean aortic valve velocity was 2.80±0.49 m/s. The median Lp(a) was 79 (64-117) mg/dL and 7 (5-11) mg/dL in the high and low Lp(a) groups, respectively. Systolic blood pressure and low-density-lipoprotein cholesterol (corrected for Lp(a)) were significantly higher in the low Lp(a) group (141±12 mm Hg vs 128±12 mm Hg, 2.5±1.1 mmol/L vs 1.9±0.8 mmol/L). We found no difference in valvular 18F-NaF uptake between the high and low Lp(a) groups (3.02±1.26 vs 3.05±0.96, p=0.902). Linear regression analysis showed valvular calcium score to be the only significant determinant of valvular 18F-NaF uptake (β=0.63; 95% CI 0.38 to 0.88 per 1000 Agatston unit increase, p<0.001). Lp(a) was not associated with 18F-NaF uptake (β=0.17; 95% CI -0.44 to 0.88, p=0.305 for the high Lp(a) group). CONCLUSION: Among patients with mild to moderate AS, calcification activity is predominantly determined by established calcium burden. The results do not support our hypothesis that Lp(a) is associated with valvular 18F-NaF uptake.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Kaiser Y, Nurmohamed NS, Kroon J, et al. Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis. Heart. 2021. PMID: 34593533. doi:10.1136/heartjnl-2021-319804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。